Abstract:
Type 2 Diabetes (T2D) affects over 500 million people, worldwide, and the cost of this disease is estimated to exceeded $970 Billion US dollars. T2D is comorbid with obesity and hypertension, and the purpose of this 6-month study was to determine if food allergy elimination is effective in reducing the HbA1c values in Pre-Diabetic (PDM) patents. Twenty-four PDM subjects (with obesity and hypertension) enrolled in this study. All subjects received nutritional counseling with aerobic exercise training, and Control (CON) subjects received no further treatment. Experimental category (EXP) subjects also had ALCAT leukocyte reaction testing to identify sub-acute food allergens (N=250 foods). Food Allergens were eliminated for the 6-month study duration. The dependent variables in this study were changes in HbA1c and BMI values. The independent variables included changes in fat mass, blood pressure, and waist circumference. Differences were calculated using a repeated measures ANOVA. The results at 180 days revealed that EXP subjects showed a mean reduction (-0.7 HbA1c), while CON showed increased values (+0.5 HbA1c), (P<0.0001). EXP also showed significant changes in BMI (-1.1), Blood pressure (-25% systolic, -20% diastolic), Fat Mass (-18 pounds), and waist circumference (-2”). There were not significant changes for CON subjects (P>0.5). This series of funded studies will include sites where incidence of T2D has shown substance growth (such as Jamaica and the Philippines) and then we will conduct a 5-year outcome study of this protocol.
